Curcumin Supplementation As a Complementary and Alternative Medicine for COVID‐19 Patients

Phytotherapy ResearchEarly View LETTER TO THE EDITOR Curcumin supplementation as a complementary and alternative medicine for COVID-19 patients Nader Aghakhani, Nader Aghakhani Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran Contribution: Conceptualization, Methodology, Validation, Writing - original draftSearch for more papers by this authorHamid Soraya, Corresponding Author Hamid Soraya [email protected] [email protected] orcid.org/0000-0003-0602-230X Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran Experimental and Applied Pharmaceutical Research Center, Urmia University of Medical Sciences, Urmia, Iran Correspondence Hamid Soraya, Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran. Email: [email protected]; [email protected] Contribution: Conceptualization, Methodology, Supervision, Validation, Writing - original draft, Writing - review & editingSearch for more papers by this author Nader Aghakhani, Nader Aghakhani Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran Contribution: Conceptualization, Methodology, Validation, Writing - original draftSearch for more papers by this authorHamid Soraya, Corresponding Author Hamid Soraya [email protected] [email protected] orcid.org/0000-0003-0602-230X Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran Experimental and Applied Pharmaceutical Research Center, Urmia University of Medical Sciences, Urmia, Iran Correspondence Hamid Soraya, Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran. Email: [email protected]; [email protected] Contribution: Conceptualization, Methodology, Supervision, Validation, Writing - original draft, Writing - review & editingSearch for more papers by this author First published: 23 March 2024 https://doi.org/10.1002/ptr.8194Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Open Research DATA AVAILABILITY STATEMENT Data sharing is not applicable to this article as no new data were created or analyzed in this study. REFERENCES Ahmadi, S., Mehrabi, Z., Zare, M., Ghadir, S., & Masoumi, S. J. (2023). Efficacy of nanocurcumin as an add-on treatment for patients hospitalized with COVID-19: A double-blind, randomized clinical trial. International Journal of Clinical Practice, 2023, 5734675. https://doi.org/10.1155/2023/5734675 10.1155/2023/5734675 PubMedWeb of Science®Google Scholar Asadirad, A., Nashibi, R., Khodadadi, A., Ghadiri, A. A., Sadeghi, M., Aminian, A., & Dehnavi, S. (2022). Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial. Phytotherapy Research, 36(2), 1023–1031. https://doi.org/10.1002/ptr.7375 10.1002/ptr.7375 CASPubMedWeb of Science®Google Scholar Askari, G., Bagherniya, M., Kiani, Z., Alikiaii, B., Mirjalili, M., Shojaei, M., Hassanizadeh, S., Vajdi, M., Feizi, A., Majeed, M., & Sahebkar, A. (2023). Evaluation of curcumin-piperine supplementation in COVID-19 patients admitted to the intensive care: A double-blind, randomized controlled trial. Advances in Experimental Medicine and Biology, 1412, 413–426. https://doi.org/10.1007/978-3-031-28012-2_22 10.1007/978-3-031-28012-2_22 CASPubMedGoogle Scholar Askari, G., Sahebkar, A., Soleimani, D., Mahdavi, A., Rafiee, S., Majeed, M., Khorvash, F., Iraj, B., Elyasi, M., Rouhani, M. H., & Bagherniya, M. (2022). The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: A randomized double-blind, placebo-controlled trial. Trials, 23(1), 472. https://doi.org/10.1186/s13063-022-06375-w 10.1186/s13063-022-06375-w CASPubMedWeb of Science®Google Scholar Fessler, S. N., Chang, Y., Liu, L., & Johnston, C. S. (2023). Curcumin confers anti-inflammatory effects in adults who recovered from COVID-19 and were subsequently vaccinated: A randomized controlled trial. Nutrients, 15(7), 1548. https://doi.org/10.3390/nu15071548 10.3390/nu15071548 CASPubMedWeb of Science®Google Scholar Gasmi, A., Chirumbolo, S., Peana, M., Noor, S., Menzel, A., Dadar, M., & Bjørklund, G. (2022). The role of diet and supplementation of natural products in COVID-19 prevention. Biological Trace Element Research, 200(1), 27–30. https://doi.org/10.1007/s12011-021-02623-3 10.1007/s12011-021-02623-3 CASPubMedWeb of Science®Google Scholar Hassaniazad, M., Eftekhar, E., Inchehsablagh, B. R., Kamali, H., Tousi, A., Jaafari, M. R., Rafat, M., Fathalipour, M., Nikoofal-Sahlabadi, S., Gouklani, H., Alizade, H., & Nikpoor, A. R. (2021). A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients. Phytotherapy Research, 35(11), 6417–6427. https://doi.org/10.1002/ptr.7294 10.1002/ptr.7294 CASPubMedWeb of Science®Google Scholar Jennings, M. R., & Parks, R. J. (2020). Curcumin as an antiviral agent. Viruses, 12(11), 1242. https://doi.org/10.3390/v12111242 10.3390/v12111242 CASPubMedGoogle Scholar Liang, D., Wen, Z., Han, W., Li, W., Pan, L., & Zhang, R. (2021). Curcumin protects against inflammation and lung injury in rats with acute pulmonary embolism with the involvement of microRNA-21/PTEN/NF-κB axis. Molecular and Cellular Biochemistry, 476(7), 2823–2835. https://doi.org/10.1007/s11010-021-04127-z 10.1007/s11010-021-04127-z CASPubMedWeb of Science®Google Scholar Mathieu, E., Ritchie, H., Rodés-Guirao, L., Appel, C., Giattino, C., Hasell, J., Macdonald, B., Dattani, S., Beltekian, D., Ortiz-Ospina, E., & Roser, M. (2020). Coronavirus Pandemic (COVID-19). Published online at OurWorldInData.org. Retrieved from: 'https://ourworldindata.org/coronavirus' [Online Resource] Google Scholar Mrozek, W., Socha, J., Sidorowicz, K., Skrok, A., Syrytczyk, A., Piątkowska-Chmiel, I., & Herbet, M. (2023). Pathogenesis and treatment of depression: Role of diet in prevention and therapy. Nutrition, 115, 112143. https://doi.org/10.1016/j.nut.2023.112143 10.1016/j.nut.2023.112143 PubMedWeb of Science®Google Scholar Pawar, K. S., Mastud, R. N., Pawar, S. K., Pawar, S. S., Bhoite, R. R., Bhoite, R. R., Kulkarni, M. V., & Deshpande, A. R. (2021). Oral curcumin with Piperine as adjuvant therapy for the treatment of COVID-19: A randomized clinical trial. Frontiers in Pharmacology, 12, 669362. https://doi.org/10.3389/fphar.2021.66936 10.3389/fphar.2021.669362 CASPubMedWeb of Science®Google Scholar Peng, Y., Ao, M., Dong, B., Jiang, Y., Yu, L., Chen, Z., Hu, C., & Xu, R. (2021). Anti-inflammatory effects of curcumin in the inflammatory diseases: Status, limitations and countermeasures. Drug Design, Development and Therapy, 15, 4503–4525. https://doi.org/10.2147/DDDT.S327378 10.2147/DDDT.S327378 CASPubMedWeb of Science®Google Scholar Saber-Moghaddam, N., Salari, S., Hejazi, S., Amini, M., Taherzadeh, Z., Eslami, S., Rezayat, S. M., Jaafari, M. R., & Elyasi, S. (2021). Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease-19 patients: An open label nonrandomized clinical trial. Phytotherapy Research, 35(5), 2616–2623. https://doi.org/10.1002/ptr.7004 10.1002/ptr.7004 CASPubMedWeb of Science®Google Scholar Shafie, E. H., Taheri, F., Alijani, N., Okhovvat, A. R., Goudarzi, R., Borumandnia, N., Aghaghazvini, L., Rezayat, S. M., Jamalimoghadamsiahkali, S., & Hosseinzadeh-Attar, M. J. (2022). Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomized double-blind placebo-controlled trial. Phytotherapy Research, 36(2), 1013–1022. https://doi.org/10.1002/ptr.7374 10.1002/ptr.7374 PubMedWeb of Science®Google Scholar Sui, Z., Salto, R., Li, J., Craik, C., & Ortiz de Montellano, P. R. (1993). Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorganic & Medicinal Chemistry, 1(6), 415–422. https://doi.org/10.1016/s0968-0896(00)82152-5 10.1016/S0968-0896(00)82152-5 CASPubMedGoogle Scholar Ting, D., Dong, N., Fang, L., Lu, J., Bi, J., Xiao, S., & Han, H. (2018). Multisite inhibitors for enteric coronavirus: Antiviral cationic carbon dots based on curcumin. ACS Applied Nano Materials, 1(10), 5451–5459. https://doi.org/10.1021/acsanm.8b00779 10.1021/acsanm.8b00779 Web of Science®Google Scholar Vahedian-Azimi, A., Abbasifard, M., Rahimi-Bashar, F., Guest, P. C., Majeed, M., Mohammadi, A., Banach, M., Jamialahmadi, T., & Sahebkar, A. (2022). Effectiveness of curcumin on outcomes of hospitalized COVID-19 patients: A systematic review of clinical trials. Nutrients, 14(2), 256. https://doi.org/10.3390/nu14020256 10.3390/nu14020256 CASPubMedWeb of Science®Google Scholar Valizadeh, H., Abdolmohammadi-Vahid, S., Danshina, S., Ziya Gencer, M., Ammari, A., Sadeghi, A., Roshangar, L., Aslani, S., Esmaeilzadeh, A., Ghaebi, M., Valizadeh, S., & Ahmadi, M. (2020). Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. International Immunopharmacology, 89(Pt B), 107088. https://doi.org/10.1016/j.intimp.2020.107088 10.1016/j.intimp.2020.107088 Web of Science®Google Scholar Wen, C. C., Kuo, Y. H., Jan, J. T., Liang, P. H., Wang, S. Y., Liu, H. G., Lee, C. K., Chang, S. T., Kuo, C. J., Lee, S. S., Hou, C. C., Hsiao, P. W., Chien, S. C., Shyur, L. F., & Yang, N. S. (2007). Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. Journal of Medicinal Chemistry, 50(17), 4087–4095. https://doi.org/10.1021/jm070295s 10.1021/jm070295s CASPubMedWeb of Science®Google Scholar World Health Organization. (2023). data.who.int, WHO Coronavirus (COVID-19) dashboard > Cases [Dashboard]. https://data.who.int/dashboards/covid19/cases Google Scholar Yavarpour-Bali, H., Ghasemi-Kasman, M., & Pirzadeh, M. (2019). Curcumin-loaded nanoparticles: A novel therapeutic strategy in treatment of central nervous system disorders. International Journal of Nanomedicine, 14, 4449–4460. https://doi.org/10.2147/IJN.S208332 10.2147/IJN.S208332 CASPubMedWeb of Science®Google Scholar Yuan, R., Li, Y., Han, S., Chen, X., Chen, J., He, J., Gao, H., Yang, Y., Yang, S., & Yang, Y. (2022). Fe-curcumin nanozyme-mediated reactive oxygen species scavenging and anti-inflammation for acute lung injury. ACS Central Science, 8(1), 10–21. https://doi.org/10.1021/acscentsci.1c00866 10.1021/acscentsci.1c00866 CASPubMedWeb of Science®Google Scholar Zahedipour, F., Hosseini, S. A., Sathyapalan, T., Majeed, M., Jamialahmadi, T., Al-Rasadi, K., Banach, M., & Sahebkar, A. (2020). Potential effects of curcumin in the treatment of COVID-19 infection. Phytotherapy Research, 34(11), 2911–2920. https://doi.org/10.1002/ptr.6738 10.1002/ptr.6738 CASPubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation